| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |